⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13451839 | 1.00 | — | — | |
| SCHEMBL13018033 | 1.00 | — | — | |
| SCHEMBL14450741 | 1.00 | — | — | |
| SCHEMBL8720661 | 1.00 | — | — | |
| SCHEMBL6693398 | 1.00 | — | — | |
| SCHEMBL8720729 | 1.00 | — | — | |
| SCHEMBL2302484 | 1.00 | — | — | |
| SCHEMBL13017712 | 1.00 | — | — | |
| SCHEMBL17850799 | 0.94 | — | — | |
| SCHEMBL12473315 | 0.92 | CA1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3760233-B1 | ONE-POT PREPARATION PROCESS FOR ANTIBODY DRUG CONJUGATE INTERMEDIATE | MABPLEX INT CO LTD (CN) | 2023-07-12 | — | — | EP | disclosed |
| WO-2023083716-A1 | ANTHRACYCLINE DERIVATIVE LINKER REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2023-05-19 | — | — | WO | disclosed |
| EP-3760233-A1 | ONE-POT PREPARATION PROCESS FOR ANTIBODY DRUG CONJUGATE INTERMEDIATE | Mabplex International, Ltd. (CN) | 2021-01-06 | — | — | EP | disclosed |
| EP-3461845-B1 | ANTI-CD33 ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH INC (US) | 2020-09-16 | — | — | EP | disclosed |
| EP-3191135-B1 | ANTI-HER2 ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH INC (US) | 2020-08-19 | — | — | EP | disclosed |
| EP-3191134-B1 | ANTHRACYCLINE DISULFIDE INTERMEDIATES, ANTIBODY-DRUG CONJUGATES AND METHODS | GENENTECH INC (US) | 2019-11-20 | — | — | EP | disclosed |
| EP-3046940-B1 | METHODS OF USING ANTI-LGR5 ANTIBODIES | HOFFMANN LA ROCHE (CH) | 2019-07-03 | — | — | EP | disclosed |
| EP-3461845-A1 | ANTI-CD33 ANTIBODIES AND IMMUNOCONJUGATES | Genentech, Inc. (US) | 2019-04-03 | — | — | EP | disclosed |
| US-10196454-B2 | Anti-PMEL17 antibodies and immunoconjugates | GENENTECH, INC. (US) | 2019-02-05 | — | — | US | disclosed |
| EP-3080164-B1 | ANTI-CD33 ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH INC (US) | 2019-01-16 | — | — | EP | disclosed |
| EP-2869850-B1 | IMMUNOCONJUGATES COMPRISING ANTI-CD79B ANTIBODIES | GENENTECH INC (US) | 2017-08-23 | — | — | EP | disclosed |
| EP-2852404-B1 | ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | GENENTECH INC (US) | 2017-07-26 | — | — | EP | disclosed |
| WO-2015143004-A9 | TARGETED THERAPEUTICS | SYNTA PHARMACEUTICALS CORP. (US) | 2016-09-29 | — | — | WO | disclosed |
| WO-2015143004-A1 | TARGETED THERAPEUTICS | SYNTA PHARMACEUTICALS CORP. (US) | 2015-09-24 | — | — | WO | disclosed |
| WO-2015134464-A2 | TARGETED THERAPEUTICS | SYNTA PHARMACEUTICALS CORP. (US) | 2015-09-11 | — | — | WO | disclosed |
| WO-2013158644-A2 | TARGETED THERAPEUTICS | SYNTA PHARMACEUTICALS CORP. (US) | 2013-10-24 | — | — | WO | disclosed |
| WO-2010009124-A2 | ANTHRACYCLINE DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR COMPOUNDS | GENENTECH, INC. (US) | 2010-01-21 | — | — | WO | disclosed |
| WO-2009099741-A1 | NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS | GENENTECH, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |